Utilidad de la plasmaféresis en pacientes con lupus eritematoso sistémico en un centro de alta complejidad del suroccidente colombiano

Aguirre-Valencia, David; Naranjo-Escobar, Juan; Posso-Osorio, Iván; Macías-Mejía, María Carmenza; Cañas, Carlos A; Obando, María-Alejandra; Barrera, Tatiana; Tobón, Gabriel J.
Medicina (Bogotá) ; 40(1(120)): 105-107, Ene-Mar, 2018.
Artículo en Español | LILACS | ID: biblio-910061

Documentos relacionados

  1. Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis-A Case Study.
  2. Safety and protection of plasma donors: A scoping review and evidence gap map.
  3. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
  4. Off with the blues: Therapeutic plasma exchange in a case of copper sulphate poisoning.
  5. A donor safety evidence literature review of the short- and long-term effects of plasmapheresis.
  6. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
  7. Plasmapheresis in the ICU.
  8. Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report.
  9. Therapeutic plasma exchange: Review of current indications.
  10. Tandem hemodialysis and DFPP: Procedure, safety and cost-effectiveness in patients requiring chronic hemodialysis and lipid apheresis.